The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Motion Sickness Pills Market Research Report 2024

Global Motion Sickness Pills Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1739072

No of Pages : 81

Ask Your Query

Synopsis
Motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.

Global Motion Sickness Pills market is projected to reach US$ 1055.7 million in 2029, increasing from US$ 854 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Motion Sickness Pills market research.

The motion sickness pills market is driven by several factors. One of the primary drivers is the increasing prevalence of motion sickness among individuals traveling by various modes of transportation, such as cars, planes, trains, and boats. Motion sickness, characterized by symptoms like nausea, dizziness, and vomiting, affects a significant portion of the population, leading to a rising demand for effective treatment options. Additionally, the growing tourism and travel industry, coupled with the increasing popularity of adventure and recreational activities, have expanded the potential consumer base for motion sickness pills. The convenience and ease of use offered by these pills, providing quick relief from symptoms, further contribute to their market growth. Moreover, advancements in drug formulations, such as non-drowsy and long-lasting options, have improved patient compliance and satisfaction. Additionally, the availability of over-the-counter options and increased accessibility of these medications in pharmacies and online platforms have further fueled the demand for motion sickness pills. Overall, the motion sickness pills market is driven by the increasing prevalence of motion sickness, expanding travel industry, advancements in drug formulations, and improved accessibility to these medications.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Motion Sickness Pills market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GlaxoSmithKline
  • Prestige Brands
  • WellSpring Pharmaceutical Corporation
  • Baxter International
  • Vartaris
  • Novartis
  • Pfizer
  • Myungmoon Pharm
  • Caleb Pharmaceuticals

Segment by Type

  • Anticholinergic
  • Antihistamines
  • Others

Segment by Application

  • Adults
  • Children

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Motion Sickness Pills report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Motion Sickness Pills Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Market by Application
1.3.1 Global Motion Sickness Pills Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Motion Sickness Pills Market Perspective (2018-2029)
2.2 Motion Sickness Pills Growth Trends by Region
2.2.1 Global Motion Sickness Pills Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Motion Sickness Pills Historic Market Size by Region (2018-2023)
2.2.3 Motion Sickness Pills Forecasted Market Size by Region (2024-2029)
2.3 Motion Sickness Pills Market Dynamics
2.3.1 Motion Sickness Pills Industry Trends
2.3.2 Motion Sickness Pills Market Drivers
2.3.3 Motion Sickness Pills Market Challenges
2.3.4 Motion Sickness Pills Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Motion Sickness Pills Players by Revenue
3.1.1 Global Top Motion Sickness Pills Players by Revenue (2018-2023)
3.1.2 Global Motion Sickness Pills Revenue Market Share by Players (2018-2023)
3.2 Global Motion Sickness Pills Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Motion Sickness Pills Revenue
3.4 Global Motion Sickness Pills Market Concentration Ratio
3.4.1 Global Motion Sickness Pills Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Motion Sickness Pills Revenue in 2022
3.5 Motion Sickness Pills Key Players Head office and Area Served
3.6 Key Players Motion Sickness Pills Product Solution and Service
3.7 Date of Enter into Motion Sickness Pills Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Motion Sickness Pills Breakdown Data by Type
4.1 Global Motion Sickness Pills Historic Market Size by Type (2018-2023)
4.2 Global Motion Sickness Pills Forecasted Market Size by Type (2024-2029)
5 Motion Sickness Pills Breakdown Data by Application
5.1 Global Motion Sickness Pills Historic Market Size by Application (2018-2023)
5.2 Global Motion Sickness Pills Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Motion Sickness Pills Market Size (2018-2029)
6.2 North America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Motion Sickness Pills Market Size by Country (2018-2023)
6.4 North America Motion Sickness Pills Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Motion Sickness Pills Market Size (2018-2029)
7.2 Europe Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Motion Sickness Pills Market Size by Country (2018-2023)
7.4 Europe Motion Sickness Pills Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Motion Sickness Pills Market Size (2018-2029)
8.2 Asia-Pacific Motion Sickness Pills Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Motion Sickness Pills Market Size by Region (2018-2023)
8.4 Asia-Pacific Motion Sickness Pills Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Motion Sickness Pills Market Size (2018-2029)
9.2 Latin America Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Motion Sickness Pills Market Size by Country (2018-2023)
9.4 Latin America Motion Sickness Pills Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Motion Sickness Pills Market Size (2018-2029)
10.2 Middle East & Africa Motion Sickness Pills Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Motion Sickness Pills Market Size by Country (2018-2023)
10.4 Middle East & Africa Motion Sickness Pills Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Motion Sickness Pills Introduction
11.1.4 GlaxoSmithKline Revenue in Motion Sickness Pills Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Development
11.2 Prestige Brands
11.2.1 Prestige Brands Company Detail
11.2.2 Prestige Brands Business Overview
11.2.3 Prestige Brands Motion Sickness Pills Introduction
11.2.4 Prestige Brands Revenue in Motion Sickness Pills Business (2018-2023)
11.2.5 Prestige Brands Recent Development
11.3 WellSpring Pharmaceutical Corporation
11.3.1 WellSpring Pharmaceutical Corporation Company Detail
11.3.2 WellSpring Pharmaceutical Corporation Business Overview
11.3.3 WellSpring Pharmaceutical Corporation Motion Sickness Pills Introduction
11.3.4 WellSpring Pharmaceutical Corporation Revenue in Motion Sickness Pills Business (2018-2023)
11.3.5 WellSpring Pharmaceutical Corporation Recent Development
11.4 Baxter International
11.4.1 Baxter International Company Detail
11.4.2 Baxter International Business Overview
11.4.3 Baxter International Motion Sickness Pills Introduction
11.4.4 Baxter International Revenue in Motion Sickness Pills Business (2018-2023)
11.4.5 Baxter International Recent Development
11.5 Vartaris
11.5.1 Vartaris Company Detail
11.5.2 Vartaris Business Overview
11.5.3 Vartaris Motion Sickness Pills Introduction
11.5.4 Vartaris Revenue in Motion Sickness Pills Business (2018-2023)
11.5.5 Vartaris Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Motion Sickness Pills Introduction
11.6.4 Novartis Revenue in Motion Sickness Pills Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Motion Sickness Pills Introduction
11.7.4 Pfizer Revenue in Motion Sickness Pills Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Myungmoon Pharm
11.8.1 Myungmoon Pharm Company Detail
11.8.2 Myungmoon Pharm Business Overview
11.8.3 Myungmoon Pharm Motion Sickness Pills Introduction
11.8.4 Myungmoon Pharm Revenue in Motion Sickness Pills Business (2018-2023)
11.8.5 Myungmoon Pharm Recent Development
11.9 Caleb Pharmaceuticals
11.9.1 Caleb Pharmaceuticals Company Detail
11.9.2 Caleb Pharmaceuticals Business Overview
11.9.3 Caleb Pharmaceuticals Motion Sickness Pills Introduction
11.9.4 Caleb Pharmaceuticals Revenue in Motion Sickness Pills Business (2018-2023)
11.9.5 Caleb Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock